Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (136)

Latest news

  • Combination Cholesterol Therapy with Reduced Statin Doses: A Smarter Way to Lower LDL
  • How to Translate Medication Names and Doses for Foreign Pharmacies
  • Gonorrhea in the LGBTQ+ Community: Key Risks and How to Stay Safe
  • Fluorouracil (5‑FU) for Colon Cancer: Full Treatment Guide
  • Side Effects After Switching to Generics: When to Worry and What to Do

Posts Tags

  • online pharmacy
  • side effects
  • medication reconciliation
  • drug interactions
  • generic medication
  • medication safety
  • dietary supplement
  • online pharmacy safety
  • patient communication
  • reemerging influenza
  • antihistamine side effects
  • alternative treatments
  • pain management
  • patent expiration
  • generic drug delay
  • Hatch-Waxman Act
  • bioequivalence
  • medication management
  • generic vs brand
  • medication errors
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.